Karolinska Development appoints Viktor Drvota as CIO
Karolinska Development AB has appointed experienced life science investor Viktor Drvota MD PhD as the firm’s new Chief Investment Officer. Terje Kalland MD PhD, the Company's Deputy Chief Executive Officer and Chief Scientific Officer, will retire from both positions effective 31 December, 2015. Dr Drvota joins Karolinska Development from SEB
